ANTON GUETH Insider Trading $ATRS ANTARES PHARMA, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANTON GUETH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANTON GUETH. ANTON GUETH is Director in ANTARES PHARMA, INC. ($ATRS).

ANTON GUETH in ANTARES PHARMA, INC.

Trading Symbol: ATRS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ANTON GUETH: Director
Holdings: 252,776 shares
Current Value: $556,107
Latest Transaction: Aug 13 2014
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ANTON GUETH in ANTARES PHARMA, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 13 2014ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyP2.005,00010,000252,776247.8 K to 252.8 K (+2.02 %)
Jun 02 2014ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseA3.0961,930191,364268,881
Sep 05 2013ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorSellS4.4225,000110,570245,976271 K to 246 K (-9.23 %)
Aug 05 2013ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorSellS4.4125,000110,355270,976296 K to 271 K (-8.45 %)
Jul 03 2013ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorSellS4.1525,000103,685295,976321 K to 296 K (-7.79 %)
Jun 05 2013ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorSellS4.0125,000100,355320,976346 K to 321 K (-7.23 %)
May 24 2013ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorGrantA0.0027,7780345,976318.2 K to 346 K (+8.73 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.6040,00064,0000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.1026,00928,6100
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM0.53174,84992,6700
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM0.85105,61689,7740
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.6561,870102,0860
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.5510,00015,5000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.5420,00030,8000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.4020,00028,0000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.401,2501,7500
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorSellS2.8587,500249,463318,198405.7 K to 318.2 K (-21.57 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9022,06763,994405,698427.8 K to 405.7 K (-5.16 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.6040,00064,000427,765387.8 K to 427.8 K (+10.32 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.909,86528,609387,765397.6 K to 387.8 K (-2.48 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.1026,00928,610397,630371.6 K to 397.6 K (+7.00 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9031,95592,670371,621403.6 K to 371.6 K (-7.92 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM0.53174,84992,670403,576228.7 K to 403.6 K (+76.44 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9030,95689,772228,727259.7 K to 228.7 K (-11.92 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM0.85105,61689,774259,683154.1 K to 259.7 K (+68.55 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9035,202102,086154,067189.3 K to 154.1 K (-18.60 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.6561,870102,086189,269127.4 K to 189.3 K (+48.56 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.905,34515,501127,399132.7 K to 127.4 K (-4.03 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.5510,00015,500132,744122.7 K to 132.7 K (+8.15 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9010,62130,801122,744133.4 K to 122.7 K (-7.96 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.5420,00030,800133,365113.4 K to 133.4 K (+17.64 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.909,65528,000113,365123 K to 113.4 K (-7.85 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.4020,00028,000123,020103 K to 123 K (+19.41 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.906031,749103,020103.6 K to 103 K (-0.58 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.401,2501,750103,623102.4 K to 103.6 K (+1.22 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM0.701,2508750
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM0.902,0001,8000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM0.955004750
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.012,0002,0200
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.325006600
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.402,0002,8000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.102,0002,2000
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.0616,50017,4900
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.135005650
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.305,7507,4750
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.90302876102,373102.7 K to 102.4 K (-0.29 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM0.701,250875102,675101.4 K to 102.7 K (+1.23 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.906211,801101,425102 K to 101.4 K (-0.61 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM0.902,0001,800102,046100 K to 102 K (+2.00 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.90164476100,046100.2 K to 100 K (-0.16 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM0.95500475100,21099.7 K to 100.2 K (+0.50 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.906972,02199,710100.4 K to 99.7 K (-0.69 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.012,0002,020100,40798.4 K to 100.4 K (+2.03 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9022866198,40798.6 K to 98.4 K (-0.23 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.3250066098,63598.1 K to 98.6 K (+0.51 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.909662,80198,13599.1 K to 98.1 K (-0.97 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.402,0002,80099,10197.1 K to 99.1 K (+2.06 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.907592,20197,10197.9 K to 97.1 K (-0.78 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.102,0002,20097,86095.9 K to 97.9 K (+2.09 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.906,03117,49095,860101.9 K to 95.9 K (-5.92 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.0616,50017,490101,89185.4 K to 101.9 K (+19.32 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.9019556685,39185.6 K to 85.4 K (-0.23 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.1350056585,58685.1 K to 85.6 K (+0.59 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorPayment of ExerciseF2.902,5787,47685,08687.7 K to 85.1 K (-2.94 %)
May 31 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.305,7507,47587,66481.9 K to 87.7 K (+7.02 %)
May 21 2012ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorGrantA0.0030,914081,91451 K to 81.9 K (+60.62 %)

Page:   1